Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Published: 20 August 2021| Version 2 | DOI: 10.17632/djj5s5nyxc.2
Contributors:
,
,
,
,
,
,
,
,
,
,
,

Description

Mendeley Supplemental Figures and Table for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Files